Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression.
about
Cortactin phosphorylated by ERK1/2 localizes to sites of dynamic actin regulation and is required for carcinoma lamellipodia persistenceFrom melanocyte to metastatic malignant melanomaMelanoma risk loci as determinants of melanoma recurrence and survivalCortactin: a multifunctional regulator of cellular invasivenessMovers and shakers: cell cytoskeleton in cancer metastasis.Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx CarcinomaHSP70 Inhibition Limits FAK-Dependent Invasion and Enhances the Response to Melanoma Treatment with BRAF Inhibitors.Inhibitory effect of quercetin on epithelial to mesenchymal transition in SK-MEL-28 human melanoma cells defined by in vitro analysis on 3D collagen gelsCortactin in cell migration and cancer at a glanceMolecular biology of normal melanocytes and melanoma cells.Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin.Expression of DIAPH1 is up-regulated in colorectal cancer and its down-regulation strongly reduces the metastatic capacity of colon carcinoma cells.The subcellular localization and activity of cortactin is regulated by acetylation and interaction with Keap1.ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma.The Arp2/3 Regulatory System and Its Deregulation in Cancer.Cortactin function in invadopodia.MTSS1 suppresses cell migration and invasion by targeting CTTN in glioblastoma.Hematopoietic lineage cell-specific protein 1 immunoreactivity indicates an increased risk of poor overall survival in patients with ovarian carcinoma.
P2860
Q27316921-FE82A806-6508-4D71-9A95-1D0ABFC28476Q34169935-E049382A-E419-483F-8A1B-FFCA9334F211Q34493237-8734FF14-A272-4BE3-9362-8488766820BBQ34891306-156932B7-A45E-444E-8DAF-E9BEA784921DQ34914057-2C1AE4E6-B749-43DB-947C-AA8ACFF3CDF7Q36617155-02872F69-5DD0-4953-A556-0413D29551DBQ37082577-74A89FBC-4AF7-48D8-8BC1-FB08FE5BD9DFQ37361994-C3AD7BEF-FE3A-4FE2-A3C3-5DC721C13EABQ38008316-95A46EB3-38ED-4877-AA8C-806F8D9DBA1BQ38092784-B2EB615F-0604-42C3-9D84-6523F2AB6835Q38747716-2510DFA3-BCFE-4F11-8D81-7EC7F7CD67E1Q39084391-8F3D5D74-51EF-48F9-B389-D9FFA5E54224Q42485470-3D7D1BF7-0E50-4423-86F4-CE72A3500FBFQ42514738-7137E230-9BFA-435C-A199-F89155143706Q47322418-71DB21B4-6342-402D-9B74-B9A4277243D3Q47367433-4D3E3A2E-BCD8-4AD8-843A-681E56A8DAD2Q48460277-3D5761F1-5ABE-4669-A5B3-C4D32179FD65Q55286596-7C375BD7-A12E-4E9B-BA42-E3EA84002504
P2860
Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cytoskeleton alterations in me ...... melanocytic tumor progression.
@ast
Cytoskeleton alterations in me ...... melanocytic tumor progression.
@en
type
label
Cytoskeleton alterations in me ...... melanocytic tumor progression.
@ast
Cytoskeleton alterations in me ...... melanocytic tumor progression.
@en
prefLabel
Cytoskeleton alterations in me ...... melanocytic tumor progression.
@ast
Cytoskeleton alterations in me ...... melanocytic tumor progression.
@en
P2093
P2860
P1433
P1476
Cytoskeleton alterations in me ...... melanocytic tumor progression.
@en
P2093
Cindy Spittle
Li-Yan Khor
Marileila Varella Garcia
R Sujatha Gajapathy
Scott Weed
Stuart R Lessin
Tian-yu Li
P2860
P2888
P304
P356
10.1038/MODPATHOL.2009.157
P577
2009-11-06T00:00:00Z
P5875
P6179
1001187543